Evolution and Increasing Complexity of the Therapeutic Landscape in Advanced Non–Small-cell Lung Cancer

Research output: Contribution to journalComment/debatepeer-review

2 Scopus citations

Abstract

The therapeutic landscape in advanced non–small-cell lung cancer (NSCLC) is rapidly changing. Never have so many changes of major importance occurred within so short a time. The present perspective describes this rapid evolution and resultant increasing complexity in the therapeutic decision-making process for the practicing oncologist.

Original languageEnglish (US)
Pages (from-to)1-4
Number of pages4
JournalClinical Lung Cancer
Volume18
Issue number1
DOIs
StatePublished - Jan 1 2017

Keywords

  • Epidermal growth factor receptor
  • NSCLC
  • Targeted therapy
  • Therapeutic landscape
  • Tyrosine kinase inhibitor

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine
  • Cancer Research

Fingerprint Dive into the research topics of 'Evolution and Increasing Complexity of the Therapeutic Landscape in Advanced Non–Small-cell Lung Cancer'. Together they form a unique fingerprint.

Cite this